CureVac to begin human trial of coronavirus vaccine
FRANKFURT (GERMANY) – German biotech firm CureVac will become the second company to begin human trials of an experimental coronavirus vaccine in the country, Germany’s vaccines regulator said on Wednesday.
Reuters reported on Tuesday that the watchdog, the Paul Ehrlich Institut, would approve testing on humans of the experimental vaccine.
(Photos syndicated via Reuters)
This story has been edited by BH staff and is published from a syndicated field